Buprenorphine
Section 8 - MEDICATION GUIDELINES
ANTICONVULSANT
Buprenorphine
DESCRIPTION / ACTION:
- Medication to treat opioid use disorder (OUD)
INDICATIONS:
- Patients precipitated opioid withdrawal who agree to start recovery and agree to transport to a designated CORE transport facility
CONTRAINDICATIONS:
- Severe hypersensitivity, including anaphylaxis and angioedema
DOSE:
- 8mg Sublingual Tablet as per Protocol